Afua Konadu Addo, Haya Mary Beydoun, Julia Edwin Jeyakumar, Shantel Olivares, Klaus J Busam, Pedram Gerami
{"title":"The Morphologic Spectrum of NF Mutated Desmoplastic Melanocytic Neoplasms.","authors":"Afua Konadu Addo, Haya Mary Beydoun, Julia Edwin Jeyakumar, Shantel Olivares, Klaus J Busam, Pedram Gerami","doi":"10.1097/DAD.0000000000003056","DOIUrl":null,"url":null,"abstract":"<p><strong>Abstract: </strong>Next generation sequencing is rapidly being integrated into diagnostic skin pathology. Critical components of this integration are studies to assist with the bioinformatic interpretation of genetic data. In this study, we characterize the morphologic and genomic spectrum of NF mutated desmoplastic melanomas (DMs) and compare them with DMs lacking pathogenic variants in NF and to NF mutated desmoplastic nevi. Relative to non- NF mutated DMs, NF mutated DMs were less likely to have an associated melanoma in situ (35% vs. 47%), less likely to have an epithelioid component (35% vs. 59%), and more likely to have prominent pigmentation (35% vs. 12%). Two distinct morphologic patterns were exclusive to the NF mutated subgroup, which included a pigmented DM mimicking blue nevi and a neurofibroma-like pattern of DM. The most common NF mutation in both specific morphologic subtypes was a truncating NF1 variant (4 of 8 and 6 of 8, respectively). Relative to NF mutated desmoplastic nevi, NF mutated DMs were more likely to have truncating variants in NF1 , had a higher TMB (57.3 vs. 9.9, P < 0.05), and a higher number of pathogenic variants (19 vs. 3, P < 0.05). Pathogenic variants in p-TERT and TP53 were exclusive to the NF mutated DMs. Alternatively, truncating variants in NF2 were mostly seen in the NF -inactivated clonal nevus. We provide the first ever description including the genomic and morphologic features of this novel combined pattern nevus typically involving an activating mutation in BRAF or other oncogene accompanied by a truncating mutation in NF2 .</p>","PeriodicalId":50967,"journal":{"name":"American Journal of Dermatopathology","volume":" ","pages":"692-698"},"PeriodicalIF":1.0000,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Dermatopathology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/DAD.0000000000003056","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Abstract: Next generation sequencing is rapidly being integrated into diagnostic skin pathology. Critical components of this integration are studies to assist with the bioinformatic interpretation of genetic data. In this study, we characterize the morphologic and genomic spectrum of NF mutated desmoplastic melanomas (DMs) and compare them with DMs lacking pathogenic variants in NF and to NF mutated desmoplastic nevi. Relative to non- NF mutated DMs, NF mutated DMs were less likely to have an associated melanoma in situ (35% vs. 47%), less likely to have an epithelioid component (35% vs. 59%), and more likely to have prominent pigmentation (35% vs. 12%). Two distinct morphologic patterns were exclusive to the NF mutated subgroup, which included a pigmented DM mimicking blue nevi and a neurofibroma-like pattern of DM. The most common NF mutation in both specific morphologic subtypes was a truncating NF1 variant (4 of 8 and 6 of 8, respectively). Relative to NF mutated desmoplastic nevi, NF mutated DMs were more likely to have truncating variants in NF1 , had a higher TMB (57.3 vs. 9.9, P < 0.05), and a higher number of pathogenic variants (19 vs. 3, P < 0.05). Pathogenic variants in p-TERT and TP53 were exclusive to the NF mutated DMs. Alternatively, truncating variants in NF2 were mostly seen in the NF -inactivated clonal nevus. We provide the first ever description including the genomic and morphologic features of this novel combined pattern nevus typically involving an activating mutation in BRAF or other oncogene accompanied by a truncating mutation in NF2 .
期刊介绍:
The American Journal of Dermatopathology offers outstanding coverage of the latest diagnostic approaches and laboratory techniques, as well as insights into contemporary social, legal, and ethical concerns. Each issue features review articles on clinical, technical, and basic science advances and illuminating, detailed case reports.
With the The American Journal of Dermatopathology you''ll be able to:
-Incorporate step-by-step coverage of new or difficult-to-diagnose conditions from their earliest histopathologic signs to confirmatory immunohistochemical and molecular studies.
-Apply the latest basic science findings and clinical approaches to your work right away.
-Tap into the skills and expertise of your peers and colleagues the world over peer-reviewed original articles, "Extraordinary cases reports", coverage of practical guidelines, and graphic presentations.
-Expand your horizons through the Journal''s idea-generating forum for debating controversial issues and learning from preeminent researchers and clinicians